Full Text
PCN90 BORTEZOMIB IS COST-EFFECTIVE FOR FIRST-LINE TREATMENT OF MULTIPLE MYELOMA IN SWEDEN

Abstract

Authors

JB Rickert J Hornberger J Liwing J Aschan L Gjnnes R Dhawan

Back to Volume 13, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×